Atlas Trials

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Clinical trial NCT07188584 · RECRUITING

Trial details

NCT number
NCT07188584
Sponsor
Ming-Yuan Chen
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma (NPC)
Start date
2025-08-20
Primary completion
2030-12-01
Enrollment
166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.